Fundraising FoxRiptide Ventures — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Sonavex develops medical device technologies focused on vascular access and related clinical applications, drawing on ultrasound-based imaging and monitoring products.
BiotechDigital HealthHealthtechMedical DevicesBaltimore, US
David Narrow(Executive Officer, Director)inDevin O'Brien-Coon(Co-Founder & Chairman)inJerry L. Prince(Co-Founder)inJohn Rappe(Executive Officer)inAlex Yevzlin(Executive Officer)
BoardRobert Hallenbeck(Director)
PartnerMike Leffer· solo GP
Co-investorsAbell Foundation, Inc.FusionGaingelsGrant Park VenturesJStar Capital InvestmentsKeiretsu Forum+5 more
__Twitter.png)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.